Tagged with IMR

Saudi Arabia Rare diseases, by definition, only affect small patient populations. However, when the more than 7,000 known rare conditions are taken together, their impact on health, societies, and economies is enormous. Moreover, over 90 percent of rare diseases have no known treatment, and rare disease patients often face delayed diagnoses and…

Saudi Arabia Dr Ahmed Alaskar, Executive Director of KAIMRC, provides an update on the development of Saudi Arabia’s growing biotech ecosystem over the past four years. He shares insights into the Kingdom’s National Biotech Strategy and the development of early-stage clinical trial capabilities. Dr. Alaskar also highlights the Kingdom’s unique advantages in…

Saudi Arabia Dr Ahmed Alaskar is executive director of the King Abdullah International Medical Research Center (KAIMRC); president of the Saudi Society of Blood and Marrow Transplantation (SSBMT); professor of Consultant Adult Hematology & HSCT at King Saud bin Abdulaziz University for Health Sciences; and chairman of the Riyadh Global Medical Biotechnology…

China Dr Li Shuai of pain- and CNS-focused Chinese biotech SIMR outlines the history of the company, the unmet medical needs it is seeking to address, its partnership strategy, and the complexities of attracting and retaining talent in the highly competitive Chinese market.   In 2014, my first angel investor actually…

Malaysia Dr. Fadzilah Kamaludin, the director of the Institute for Medical Research (IMR) in Malaysia, highlights the important role of the IMR, as a public organization, to help the research in key therapeutic areas and its ambitions to help commercialize solutions that will benefit patients in Malaysia and around the world.…